We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
-19.5%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
–
AUM
$73.2M
AUM Growth
-$24.1M
Cap. Flow
-$2.48M
Cap. Flow %
-3.39%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
1
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
CBLL
CeriBell Inc
CBLL
+$2.23M

Top Sells

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$4M
2
CSTL icon
Castle Biosciences
CSTL
+$451K
3
SGMT icon
Sagimet Biosciences
SGMT
+$186K
4
PYXS icon
Pyxis Oncology
PYXS
+$67.9K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMTS
1
Kestra Medical Technologies
KMTS
$1.43B
$37.8M 51.71%
2,282,519
– –
CBLL
2
CeriBell Inc
CBLL
$710M
$25.3M 34.63%
1,353,166
+130,964
+11% +$2.23M
WHWK
3
Whitehawk Therapeutics
WHWK
$192M
$3.87M 5.29%
2,070,000
– –
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
$3.76M 5.13%
912,000
– –
ALMS
5
Alumis Inc
ALMS
$3.65B
$2.37M 3.24%
789,618
– –
CGON icon
6
CG Oncology
CGON
$6.34B
– –
-163,456
Closed -$4M
CSTL icon
7
Castle Biosciences
CSTL
$733M
– –
-22,503
Closed -$451K
PYXS icon
8
Pyxis Oncology
PYXS
$150M
– –
-69,303
Closed -$67.9K
SGMT icon
9
Sagimet Biosciences
SGMT
$483M
– –
-57,190
Closed -$186K

Similar funds

PWM
Partners Wealth Management Carmel By The Sea, California $97M AUM 15.73% 1-Year Est. Return
ACM
Arrington Capital Management Miami, Florida $97.1M AUM
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $97.3M AUM 26.15% 1-Year Est. Return
SFO
Standard Family Office Sioux Falls, South Dakota $96.8M AUM 17.11% 1-Year Est. Return
CSW
Cogent Strategic Wealth Chicago, Illinois $97.3M AUM
TFS
truNorth Financial Services Chambersburg, Pennsylvania $96.7M AUM
FA
Fullerton Advisors Danville, California $96.6M AUM
JKSF
John & Kathleen Schreiber Foundation Lake Forest, Illinois $97.5M AUM 13.8% 1-Year Est. Return

Yu Fan's Q2 2025 Portfolio in Review

As of Q2 2025, Yu Fan held 9 positions worth $73.2M, down 25% from $97.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan withdrew a net $2.48M in Q2 2025, closing 4 positions. Its most notable exit was CG Oncology, an estimated $4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Yu Fan added an estimated $2.23M to CeriBell Inc.

  • Yu Fan added most to CeriBell Inc in Q2 2025, an estimated $2.23M increase.
  • Yu Fan fully exited CG Oncology in Q2 2025, selling an estimated $4M.
  • Yu Fan's ten largest holdings make up 100% of its $73.2M portfolio in Q2 2025.
  • Yu Fan opened 0 new positions and closed 4 in Q2 2025.
  • Yu Fan's portfolio value fell 25% quarter-over-quarter to $73.2M.

Based on Yu Fan's 13F filing for Q2 2025, filed 14 Aug 2025.